International Platform of Registered Systematic Review and Meta-analysis Protocols
INPLASY202260105
Discontinuation Rate with Tadalafil Alone or in Combination with a-Blockers for Treatment of Male Lower Urinary Tract Symptoms with or without coexisting Erectile Dysfunction